Abstract Copper is a nutritional metal required for brain development and function. Wilson's disease (WD), or hepatolenticular degeneration, is an inherited human copper metabolism disorder caused by a mutation of the ATP7B gene. Many WD patients present with variable neurological and psychiatric symptoms, which may be related to neurodegeneration secondary to copper metabolism imbalance. The objective of this study was to explore the feasibility and use of copper-64 chloride ([ 
Introduction
Copper is an essential nutrient required for development and function of the human brain (Olivares and Uauy 1996; Uauy et al. 1998 ). Wilson's disease (WD) is an inherited copper metabolism disorder caused by mutation of the ATP7B gene encoding a copper-transporting P-type ATPase functioning as an efflux copper transporter (Bull et al. 1993; Tanzi et al. 1993; Yamaguchi et al. 1993) . The ATP7B efflux copper transporter is highly expressed in the liver and plays an important role in the delivery and biliary excretion of copper from the liver. Malfunction of the ATP7B efflux copper transporter causes accumulation of an excess amount of copper ions in the liver, resulting in hepatic metabolic changes and liver tissue damage. The ATP7B protein is also expressed in the brain and plays an important role in maintenance of cerebral copper homeostasis. Development of neurological and behavioral disorders in some WD patients is likely related to disruption of copper homeostasis in the brain due to malfunction of the ATP7B protein. The molecular mechanism underlying the diverse presentation of neuropsychiatric symptoms in WD patients remains unclear, largely due to lack of a tool for real-time assessment of changes in cerebral copper metabolism related to neurodegeneration in the brains of WD patients. Positron emission tomography (PET) is a valuable technology for functional imaging of cerebral metabolic activity in vivo based on its high sensitivity and quantification capability. Recently, the biodistribution and radiation dosimetry of [ 64 Cu]CuCl 2 in Atp7b −/− knockout mice, a well-established mouse model of WD, was determined by PET/CT analysis (Peng et al. 2012a, b) . Exploring feasibility and use of [ (Som et al. 1980) , which is widely used as a PET tracer for assessment of changes of cerebral glucose metabolism in neurological and psychiatric disorders. In order to determine whether [ (Gray et al. 2012; Peng et al. 2012a, b) . The data from this preclinical study support further study of [ 64 Cu]CuCl 2 as a new PET tracer for assessment of age-dependent changes of copper metabolism in WD patients presenting with neuropsychiatric symptoms.
Materials and methods

Small animals and radiopharmaceuticals
Balb/c mice were purchased from the animal resource center of the University of Texas Southwestern Medical Center (Dallas, TX) and housed in the animal housing facility, UT Southwestern Medical Center at Dallas, with free access to copper-adequate food and drinking water. (Fueger et al. 2006; Toyama et al. 2004) . In short, Balb/c mice were anesthetized by inhalation of 3% isoflurane in 100% oxygen (3 L/min) at room temperature, using an isoflurane vaporizer (Summit Anesthesia Solutions, Salt Lake City, UT) and scanned using a Siemens Inveon PET/CT multimodality system (Siemens Medical Solutions). The mice were placed on the imaging bed in a spread-supine position and subjected to inhalation of 2% isoflurane in 100% oxygen (3 L/min) during the PET/ CT procedure. After intravenous injection of [
18 F]FDG (2 μCi (74 kBq)/g body weight) via the tail vein, dynamic data acquisition was started at 30 min p.i. with the head in the center of the field of view (FOV) and continued for 30 min (6 × 5 min). At 2 h p.i., a static whole-body scan was performed for a duration of 15 min. PET/CT images were reconstructed using the ordered subsets expectation maximization 3D algorithm (OSEM3D), and data was analyzed using the Inveon Research Workplace (IRW) software (Siemens) which allows fusion of CT and PET image volumes. Cu]CuCl 2 -PET/CT imaging of Balb/c mice was performed using a method described previously (Peng et al. 2012a, b) . Briefly, Balb/c mice were anesthetized by 3% isoflurane in 100% oxygen (3 L/min) at room temperature, using an isoflurane vaporizer (Summit Anesthesia Solutions, Salt Lake City, UT). The mice were positioned in a spread-supine position on the imaging bed and subjected to inhalation of 2% isoflurane in 100% oxygen (3 L/min) during the PET/CT procedure. PET/CT imaging was then initiated following intravenous injection of [ 64 Cu]CuCl 2 (2 μCi (74 kBq)/g body weight) diluted in a volume of 100 μL normal saline (0.9% sodium chloride) via the tail vein. Dynamic whole body data acquisition was started for 30 min (5 min frames) with the head in the center of the field of view (FOV), followed by static whole body scan for 15 min at 2 h and 24 h p.i, respectively. PET/ CT images were reconstructed using the ordered subsets expectation maximization 3D algorithm (OSEM3D), and data was analyzed using the Inveon Research Workplace (IRW) software (Siemens) which allows fusion of CT and PET image volumes.
Quantification of copper ions in mouse tissues by ICP-MS
To investigate the correlation of Cu radioactivity measured by [ 64 Cu]CuCl 2 -PET/CT with copper ions present in mouse organs or tissues, mouse tissue copper ions in another group of Blab/c mice (n = 5, female, 8 weeks of age) were quantified by Inductively coupled plasma mass spectrometry (ICP-MS) in a method similar to those previously described (Faa et al. 2001; Gray et al. 2012) . For sample preparation, mouse tissues were harvested after the Balb/c mice were euthanized under anesthesia. Tissues and organs were frozen for further study. The collected tissues were weighed, and 200 μL of fresh aqua regia (a mixture of nitric acid and hydrochloric acid nitric in a ratio of 1:3, tracer metal grade) purchased from Fisher scientific (Pittsburgh, PA) were added to these tissues, followed by heating to 80°C for 20 min. Ultrasonication was utilized to aid digestion of these tissues. After overnight digestion, all of the sample solutions were clear, without visible residues. The solution was diluted with Milli-Q water (Millipore gradient, USA) for ICP-MS determination. Copper analysis was performed with a 7700 series ICP-MS instrument (Agilent technologies, CA). Calibration was performed using 6 to 8 standards and stable copper isotopes were measured with instrumental parameters. Copper concentration was recorded as ng/mg wet weight and values presented as means ± standard deviation (SD). Cu radioactivity in the different regions of a mouse brain, 9 regions of interest (ROIs) were defined manually on the PET/CT images with reference to an MR imaging-based atlas of mouse brain anatomy (Chuang et al. 2011) as shown on Fig. 2 . Regions included were: ROI 1 for olfactory bulb (OB), ROI 2 for frontal cortex (FC), ROI 3 for posterior cortex (PC), ROI 4 for hippocampus (HC), ROI 5 for basal ganglia (BG), ROI 6 for thalamus (T), ROI 7 for middle brain (MB), ROI 8 for brain stem (BS), ROI 9 for cerebellum (CB). The quantity of 64 Cu radiotracer activity was obtained and recorded as a percentage of injected dose per gram tissue (%ID/g).
Statistical analysis
Friedman rank based ANOVA was used to test the difference in median cerebral 64 Cu radioactivity between Atp7b −/− knockout mice and control C57BL/6 mice for each organ and for each time point (2 h and 24 h p.i., respectively). A P value of less than 0.05 was considered as statistically significant. Cu radioactivity in the cerebellum (Fig. 2 , Table 2 ).
Copper concentration of mouse tissues determined by ICP-MS
Copper concentration in the tissues of Balb/c mice (n = 5, female, 8th weeks of age) was quantified by ICP-MS. A high concentration of copper ions was detected in the heart (7.49 ± 1.04 ng/mg), liver (6.51 ± 1.22 ng/mg), brain (5.66 ± 0.97), stomach (5.46 ± 1.57 ng/mg), and kidney (4.27 ± 0.93 ng/mg), compared with relatively lower concentration of copper ions in the lungs (3.23 ± 0.88 ng/mg), muscle (2.31 ± 0.79 ng/mg), intestine (2.39 ± 0.49 ng/mg), and spleen (1.68 ± 0.68 ng/mg). High copper concentration in liver tissue was correlated with abundant hepatic Quantitative analysis was performed to study 64 Cu radioactivity in the brain of Atp7b −/− knockout mice injected with 64 CuCl 2 intravenously, using the data from a recent study of 64 Cu biodistribution and radiation dosimetry in Atp7b −/− knockout mice (Peng et al. 2012a) . By the 7th weeks of age,
64
Cu radioactivity at 24 h p.i. in the brain of Atp7b −/− knockout mice (0.34 ± 0.08%ID/g) was significantly lower than the 64 Cu radioactivity in the brains of age-matched C57BL/6 mice (0.61 ± 0.09%ID/g, p < 0.03) (Fig. 4, Table 3 ). Moreover, whereas the brain 64 Cu radioactivity of control C57BL/6 mice increased between 2 and 24 h p.i., it was decreased between 2 and 24 h p.i. in the brain of Atp7b −/− knockout mice. Cu radioactivity in the brains of Atp7b −/− knockout mice (0.05 ± 0.04%ID/g) was lower than 64 Cu radioactivity in the brains of control C57BL/6 mice (0.11 ± 0.10%ID/g, p = 0.048). Subsequently, there was an age-dependent increase of Cu radioactivity in the corresponding brain regions of control C57BL/6 mice ( Table 4 ).
Discussion
Copper is required for development and function of the brain, and copper metabolism imbalance secondary to malfunction of ATP7B efflux copper transporter causes neurodegeneration in WD (Ala et al. 2007; Lorincz 2010) . Some WD patients Fig. 1 , as well as other modification factors (Lutsenko 2014) . Animals with genetic defects in the Atp7b gene have been a remarkably useful tool in the study of molecular mechanisms related to WD pathophysiology. The Atp7b −/− knockout mouse is a well-established mouse model of WD, developing hepatic pathology caused by accumulation of excess amount of copper ions in the liver (Buiakova et al. 1999; Lutsenko 2008) . In contrast to neuroinflammatory and behavioral changes observed in the toxic milk mouse model of WD (Przybyłkowski et al. 2013; Terwel et al. 2011) , no significant neuropsychiatric symptoms were observed in adult Atp7b −/− knockout mice, although neurological symptoms (tremor, ataxia, abnormal locomotor behavior) were observed in Atp7b −/− knockout pups younger than 2 weeks of age and nursed by homozygous Atp7b −/− mothers (Lutsenko 2008 ).
The cause of absence of neuropsychiatric symptoms in adult Atp7b −/− knockout mice is not clear, it may be related to agedependent changes of cerebral copper metabolism. Cerebral copper deficiency that is present at an infant age is no longer present in the adult Atp7b −/− knockout mice, most likely due to improvement of availability and delivery of copper to the brain tissues. It remains to be determined whether old Atp7b −/− knockout mice will develop neuropsychiatric symptoms in the case of neuron loss caused by neurotoxicity of an excess amount of copper ions accumulated in the brain tissues. (Wang et al. 2010) , investigation of changes of cerebral copper metabolism in a mouse model of Menkes disease (Nomura et al. 2014) , as well as diagnostic imaging of traumatic brain injury (Peng et al. 2015) . To determine whether (Fig. 3) . Although intense 64 Cu radioactivity in the liver is correlated with a large quantity of hepatic endogenous copper ions measured by ICP-MS, there was no direct correlation between relatively low cerebral 64 Cu radioactivity determined by PET/CT and high concentration of copper ions in brain tissues determined by ICP-MS (Fig. 3) . This finding suggests that [ Cu in mouse brain tissues, while ICP-MS measures the total amount of endogenous copper ions in mouse brain tissues, which is regulated by a network of copper transporters and chaperons (Lutsenko et al. 2010; Madsen and Gitlin 2007; Zhou and Gitschier 1997) . Thus it is important to study both the changes of dynamic copper flux and quantity of endogenous copper ions in brain tissues in dissecting copper metabolism imbalance, either copper deficiency or accumulation of an excess amount of copper ions, in pathophysiology of WD Faa et al. 2001; Litwin et al. 2013 ) as well as other neurological disease associated with copper metabolism disorders (Madsen and Gitlin 2007) . Cu radioactivity in the brains of age-matched control C57BL/6 mice ( Fig. 4 and Table 3 ). Low (Fig. 3b) were obtained in Balb/c (Hawkins et al. 1987; Hermann et al. 2002) and MRI (Hermann 2014; Hermann et al. 2002) . Delineation of age-dependent changes of copper metabolism in WD patients is expected to contribute to a better understanding of the molecular mechanism of neurodegeneration in WD. In summary, 64 CuCl 2 -PET/CT is a promising new tool for assessment of the changes of cerebral copper metabolism in WD patients who present with psychiatric and neurological symptoms and may set the stage for individualized treatment of WD (Ala et al. 2007; Lorincz 2010; Roberts and Schilsky 2008 
